Skip to content

XIENCE XPEDITION 1074300-12Recalls & reported problems

Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 3.00 mm x 12 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE XPEDITION (41)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162329), received between Mar 2, 2017 and Mar 2, 2017 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Angina1
  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 2, 2017Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THREE XIENCE XPEDITION STENTS (2.25 X 18 MM. 2.25 X 08 MM AND 3.0 X 12 MM) WERE IMPLANTED IN THE RIGHT CORONARY ARTERY ON (B)(6) 2014. THE PATIENT WAS RE-ADMITTED WITH CHEST PAIN AND RESTENOSIS IN THE STENTS WAS FOUND WHICH WAS TREATED WITH TWO NON-ABBOTT STENTS. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. THE PATIENT IS DOING GOOD. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Angina; Stenosis

    MAUDE report 6374758 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page